Welcome to our dedicated page for Albemarle news (Ticker: ALB), a resource for investors and traders seeking the latest updates and insights on Albemarle stock.
Albemarle Corporation reports news on its role as a global producer of lithium and bromine used in mobility, energy, connectivity and health applications. Company updates commonly cover Energy Storage and Specialties performance, lithium market pricing and volumes, bromine-based solutions, operational productivity, and cash generation.
Recurring developments also include quarterly earnings releases, common stock dividends, debt tender offers and note redemptions, board and committee appointments, and portfolio actions. Recent corporate updates include the completed sale of a controlling stake in Ketjen's refining catalyst solutions business, Albemarle's retained minority interest in Ketjen, and the integration of Performance Catalyst Solutions into Albemarle's product portfolio.
Albemarle (NYSE: ALB) launched cash tender offers for four series of senior notes with an Offer Cap of $500 million and will fully redeem its $650 million 4.650% senior notes due 2027 on March 12, 2026.
Early Tender Time is March 13, 2026; Offers expire March 30, 2026; Early Settlement expected March 18, 2026; Final Settlement April 1, 2026. Each accepted tender pays a $50 per $1,000 early tender premium.
Albemarle (NYSE: ALB) completed sale of a controlling stake in Ketjen's refining catalyst solutions business to KPS Capital Partners on March 2, 2026, while retaining a minority stake and full ownership of Ketjen's Performance Catalyst Solutions business, which Albemarle integrated into its portfolio. Combined with a January 2026 sale of a 50% Eurecat interest, Albemarle received $670 million in pre-tax proceeds to be used for debt reduction and general corporate purposes.
Albemarle (NYSE: ALB) declared a quarterly common stock dividend of $0.405 per share, equal to an annualized rate of $1.62. The dividend is payable April 1, 2026 to shareholders of record at the close of business on March 13, 2026.
The announcement reiterates standard forward-looking disclosures and references factors that could affect future dividends and results.
Albemarle (NYSE: ALB) will idle Train 1 at its Kemerton lithium hydroxide plant in Western Australia and place it into care and maintenance effective immediately. This follows 2024 actions to idle Train 2 and to cease expansion plans for Trains 3 and 4.
The plant processes spodumene from Greenbushes. Albemarle said the decision improves financial flexibility, is expected to be accretive to adjusted EBITDA beginning in Q2 2026, and will not affect projected 2026 volumes. Mining interests in Australia remain unchanged.
Albemarle (NYSE: ALB) reported Q4 2025 net sales of $1.4 billion, up 16% year-over-year, and a Q4 net loss of ($414) million, or ($3.87) per share, driven by tax items and a Ketjen-related asset write-down. Adjusted EBITDA was $269 million, up 7%.
Full-year 2025 cash from operations was $1.3 billion, free cash flow $692 million, capex $590 million, and the company expects FY2026 outcomes across lithium price scenarios with capex ~ $550–$600 million.
Albemarle (NYSE: ALB) will release its fourth quarter 2025 earnings after the NYSE close on Wednesday, February 11, 2026. The company will host a conference call to discuss results on Thursday, February 12, 2026 at 8:00 a.m. EST, accessible via webcast or direct dial (Conference ID: ALBQ4).
Participant dial-in numbers and an attendee URL are provided for live access, and a webcast replay will be available after the event on Albemarle's News and Events/investor website.
Lithium Royalty Corp (TSX: LIRC) congratulated Power Metals on a cesium concentrate offtake agreement between Power Metals and Albemarle (NYSE: ALB), including a prepayment facility of up to C$5 million. LIRC holds a 2.0% gross overriding royalty on the Case Lake project, which hosts a maiden inferred cesium resource of 13,000 tonnes at 2.4% Cs2O (0.1% cutoff) from West Joe Dyke. Power Metals reaffirmed a 2026 production target and reported exploration upside with an additional target of 11,000–15,000 tonnes plus 17 untested targets. Management cited project capital requirements of under C$8 million.
Albemarle (NYSE: ALB) reported third-quarter 2025 results for the period ended September 30, 2025. Net sales were $1.3 billion, Adjusted EBITDA was $225.6 million (up 6.7% YoY) and the company reported a net loss of ($161) million, or ($1.72) per diluted share. On an adjusted basis, diluted loss was ($0.19) per share excluding a Ketjen goodwill impairment. Cash from operations for Q3 was $356 million (up 57% YoY); year-to-date cash from operations was $894 million.
Management reduced full-year capex to ~ $600 million, expects positive free cash flow of $300–$400 million for 2025, and announced combined pre-tax proceeds of ~ $660 million from sale agreements for stakes in Ketjen and Eurecat.
Albemarle (NYSE: ALB) declared a quarterly common stock dividend of $0.405 per share, equal to an annualized rate of $1.62. The dividend is payable on January 2, 2026 to shareholders of record at the close of business on December 12, 2025.
The announcement reiterates Albemarle's routine shareholder distribution practice and includes forward-looking cautionary language about factors that could cause actual results to differ from expectations.
KPS Capital Partners will acquire a controlling stake in Ketjen from Albemarle (NYSE: ALB), with KPS and Albemarle affiliates owning approximately 51% and 49% of Ketjen at closing, respectively.
KPS will hold a majority of the board and operational control. Albemarle will retain 100% of Ketjen's Performance Catalyst Solutions (PCS) business. The transaction is expected to close in Q1 2026 and is subject to customary closing conditions and approvals.
Ketjen is headquartered in Houston, has ~840 employees, two manufacturing facilities, two research and technology centers and two joint ventures across the Americas, Europe and Asia. Committed debt financing was provided by Barclays, Jefferies, BNP Paribas and Santander.